Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leonardo Calza

Showing results (181-190 of 188) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 188 results.
Plos One|June 21, 2017
Safety and tolerability of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) projectNicola Squillace, Elena Ricci, Tiziana Quirino, et al.
Infection and Drug Resistance|May 8, 2018
Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA ProjectPaola Bagella, Giuseppe Vl De Socio, Elena Ricci, et al.
The Journal of Antimicrobial Chemotherapy|August 12, 2025
A multicentre real-life prospective cohort study on effectiveness, durability and safety of long-acting injectable cabotegravir and rilpivirine in northern Italy: the LONGITUDE studyMaria Mazzitelli, Claudia Cozzolino, Dina Yaacoub, et al.
BMC Infectious Diseases|September 23, 2022
Growing old with antiretroviral therapy or elderly people in antiretroviral therapy: two different profiles of comorbidity?Paolo Maggi, Giuseppe Vittorio De Socio, Barbara Menzaghi, et al.
Open Forum Infectious Diseases|June 25, 2020
Factors Associated With Weight Gain in People Treated With DolutegravirLucia Taramasso, Paolo Bonfanti, Elena Ricci, et al.
AIDS Patient Care and Stds|September 15, 2021
Durability of Dolutegravir-Based Regimens: A 5-Year Prospective Observational StudyLucia Taramasso, Andrea De Vito, Elena Delfina Ricci, et al.
Viruses|July 29, 2023
Lipids and Transaminase in Antiretroviral-Treatment-Experienced People Living with HIV, Switching to a Doravirine-Based vs. a Rilpivirine-Based Regimen: Data from a Real-Life SettingPaolo Maggi, Elena Delfina Ricci, Canio Vito Martinelli, et al.
Viruses|April 27, 2024
Risk of Cardiovascular Events in People with HIV (PWH) Treated with Integrase Strand-Transfer Inhibitors: The Debate Is Not Over; Results of the SCOLTA StudyNicolò Corti, Barbara Menzaghi, Giancarlo Orofino, et al.
Pageof 19

Showing results (181-190 of 188) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 188 results.
Plos One|June 21, 2017
Safety and tolerability of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) projectNicola Squillace, Elena Ricci, Tiziana Quirino, et al.
Infection and Drug Resistance|May 8, 2018
Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA ProjectPaola Bagella, Giuseppe Vl De Socio, Elena Ricci, et al.
The Journal of Antimicrobial Chemotherapy|August 12, 2025
A multicentre real-life prospective cohort study on effectiveness, durability and safety of long-acting injectable cabotegravir and rilpivirine in northern Italy: the LONGITUDE studyMaria Mazzitelli, Claudia Cozzolino, Dina Yaacoub, et al.
BMC Infectious Diseases|September 23, 2022
Growing old with antiretroviral therapy or elderly people in antiretroviral therapy: two different profiles of comorbidity?Paolo Maggi, Giuseppe Vittorio De Socio, Barbara Menzaghi, et al.
Open Forum Infectious Diseases|June 25, 2020
Factors Associated With Weight Gain in People Treated With DolutegravirLucia Taramasso, Paolo Bonfanti, Elena Ricci, et al.
AIDS Patient Care and Stds|September 15, 2021
Durability of Dolutegravir-Based Regimens: A 5-Year Prospective Observational StudyLucia Taramasso, Andrea De Vito, Elena Delfina Ricci, et al.
Viruses|July 29, 2023
Lipids and Transaminase in Antiretroviral-Treatment-Experienced People Living with HIV, Switching to a Doravirine-Based vs. a Rilpivirine-Based Regimen: Data from a Real-Life SettingPaolo Maggi, Elena Delfina Ricci, Canio Vito Martinelli, et al.
Viruses|April 27, 2024
Risk of Cardiovascular Events in People with HIV (PWH) Treated with Integrase Strand-Transfer Inhibitors: The Debate Is Not Over; Results of the SCOLTA StudyNicolò Corti, Barbara Menzaghi, Giancarlo Orofino, et al.
Pageof 19